
Oncology Market Size Was Valued at USD 221.36 Billion in 2023 and is Projected to Reach USD 474.06 Billion by 2032, Growing at a CAGR of 8.83% From 2024-2032.
Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer which involves the study of tumours, cancer cells, and their growth, as well as the development of effective treatments for cancer patients.Oncology plays a crucial role in the early detection and accurate diagnosis of cancer involving various screening methods, imaging techniques, and tests to identify the presence and stage of cancer in patients.
Oncologists consider factors like cancer type, stage, patient's health condition, and individual needs to determine the most effective treatment options, including surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapies.Oncology is pushing for in-depth research to uncover the reasons and processes behind the development of cancer. This study contributes to the advancement of novel treatment options, ground-breaking medications, and enhanced therapies, resulting in improved results for individuals with cancer.Oncology has a significant impact on public health initiatives related to cancer prevention and control which includes promoting awareness about risk factors, encouraging cancer screenings, advocating for vaccination programs, and implementing tobacco control measures to reduce cancer incidence.
“Roche Holding AG (Switzerland), Bristol Myers Squibb (United States), Kura Oncology, Inc. (United States), Johnson & Johnson (United States), Pfizer Inc. (United States), AstraZeneca (United Kingdom), Merck & Co., Inc. (United States), Novartis AG (Switzerland), AbbVie Inc. (United States), Abbott Laboratories (United States), Amgen Inc. (United States), Sanofi SA (France), Bristol-Myers Squibb Company (United States), Gilead Sciences Inc (United States), Vertex Pharmaceuticals Inc. (United States), Regeneron Pharmaceuticals Inc. (United States), GSK plc. (United Kingdom), Daiichi Sankyo Company Ltd. (Japan), Takeda Pharmaceutical Company Ltd. (Japan), Moderna Inc. (United States), Biogen Inc. (United States), BioNTech SE (Germany), Astellas Pharma Inc. (Japan), Illumina Inc. (United States), Beigene Ltd. (China), and Other Active Players.”
The Oncology Market is Segmented on the basis of Diagnostics & Treatment, Treatment, Drugs Class, Dosage Form, Indication, Distribution Channel, And End-user.
There are two segments by diagnostics & treatment such as diagnostics which contain sub-segments biopsy, imaging, immunohistochemistry, tumour biomarkers test, in situ hybridization, and liquid biopsy and treatment which contains sub-segments targeted therapy, chemotherapy, hormonal therapy, and immunotherapy. Among these, the treatment segment is expected to dominate the market during the forecast period.
There are six segments by application such as lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, and others (head & neck cancer, prostate cancer, thyroid cancer). Among these, the lung cancer segment held the largest share in 2023.
Oncology Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 221.36 Bn. |
Forecast Period 2024-32 CAGR: |
8.83 % |
Market Size in 2032: |
USD 474.06 Bn. |
Segments Covered: |
By Diagnostics & Treatment |
|
|
By Drugs Class |
|
||
By Dosage Form |
|
||
By Indication |
|
||
By Distribution Channel |
|
||
By End-user |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Oncology Market by By Diagnostics & Treatment
4.1 Oncology Market Snapshot and Growth Engine
4.2 Oncology Market Overview
4.3 Diagnostics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and
The forecast period in the Oncology Market research report is 2024-2032.
Roche Holding AG (Switzerland), Bristol Myers Squibb (United States), Kura Oncology, Inc. (United States), Johnson & Johnson (United States), Pfizer Inc. (United States), AstraZeneca (United Kingdom), Merck & Co., Inc. (United States), Novartis AG (Switzerland), AbbVie Inc. (United States), Abbott Laboratories (United States), Amgen Inc. (United States), Sanofi SA (France), Bristol-Myers Squibb Company (United States), Gilead Sciences Inc (United States), Vertex Pharmaceuticals Inc. (United States), Regeneron Pharmaceuticals Inc. (United States), GSK plc. (United Kingdom), Daiichi Sankyo Company Ltd. (Japan), Takeda Pharmaceutical Company Ltd. (Japan), Moderna Inc (United States), Biogen Inc. (United States), BioNTech SE (Germany), Astellas Pharma Inc. (Japan), Illumina Inc. (United States), Beigene Ltd. (China), and Other Active Players.
The Oncology Market is segmented into Diagnostics & Treatment, Treatment, Drugs Class, Dosage Form, Indication, Distribution Channel, End-user, and Region. By Diagnostics & Treatment, the market is categorized into Diagnostics (Biopsy, Imaging, Immunohistochemistry, Tumor Biomarkers Test, In Situ Hybridization, And Liquid Biopsy), Treatment, (Targeted Therapy, Chemotherapy, Hormonal Therapy, Immunotherapy). By Drugs Class, the market is categorized into Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Immunomodulatory Drugs. By Dosage Form, the market is categorized into Solid, Liquid, and Injectable. By Indication, The Market Is Categorized into Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, And Others (Head & Neck Cancer, Prostate Cancer, Thyroid Cancer). By Distribution Channel, the market is categorized Into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By End-user, the market is categorized into Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, and Specialty Clinics. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer which involves the study of tumors, cancer cells, and their growth, as well as the development of effective treatments for cancer patients.
Oncology Market Size Was Valued at USD 221.36 Billion in 2023 and is Projected to Reach USD 474.06 Billion by 2032, Growing at a CAGR of 8.83% From 2024-2032.